Nuveen Floating Rate Income Fund Dividend Insights: Key Details Before Aug 15, 2025 Ex-Dividend Date
Generated by AI AgentAinvest Dividend Digest
Monday, Aug 11, 2025 7:57 pm ET1min read
JFR--
Aime Summary
Nuveen Floating Rate Income Fund (JFR) has announced its upcoming dividend distribution, with an ex-dividend date set for Aug 15, 2025, and a payable date on Sep 2, 2025. The declared dividend amount is $0.085 per share, which is higher compared to the average of the last ten dividends per share, which stands at $0.065. On Aug 1, 2025, the company announced its latest dividend, maintaining the same per-share amount of $0.085. The dividend type for both instances is cash dividend.
Recently, Nuveen Floating Rate Income FundJFR-- has declared a monthly dividend of $0.085 per share, boasting a forward yield of 12.01%. This dividend is payable on Sept 2, 2025, for shareholders of record as of Aug 15, 2025. As of late, the fund's stock price has shown notable activity, with recent reports indicating fluctuations between $8.54 and $8.52 as of Aug 8, 2025. Analysts have upgraded the stock to a Buy Candidate, highlighting its strong performance and positive trading levels. Over the past week, there has been considerable attention on JFR's earnings revisions, with updates pointing to trends in revenue and EPS for the upcoming quarter and fiscal years. These developments reflect the fund's robust financial health and potential for continued growth within its sector.
In conclusion, the ex-dividend date for Nuveen Floating Rate Income Fund is Aug 15, 2025. Investors should note that this is the last day to purchase shares to be eligible for the upcoming dividend; any acquisitions post this date will not qualify for the dividend distribution this time.
Recently, Nuveen Floating Rate Income FundJFR-- has declared a monthly dividend of $0.085 per share, boasting a forward yield of 12.01%. This dividend is payable on Sept 2, 2025, for shareholders of record as of Aug 15, 2025. As of late, the fund's stock price has shown notable activity, with recent reports indicating fluctuations between $8.54 and $8.52 as of Aug 8, 2025. Analysts have upgraded the stock to a Buy Candidate, highlighting its strong performance and positive trading levels. Over the past week, there has been considerable attention on JFR's earnings revisions, with updates pointing to trends in revenue and EPS for the upcoming quarter and fiscal years. These developments reflect the fund's robust financial health and potential for continued growth within its sector.
In conclusion, the ex-dividend date for Nuveen Floating Rate Income Fund is Aug 15, 2025. Investors should note that this is the last day to purchase shares to be eligible for the upcoming dividend; any acquisitions post this date will not qualify for the dividend distribution this time.

Sip from the stream of US stock dividends. Your income play.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet